Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease [Phase 3]
A Phase 3 clinical trial evaluating two doses of EVP-6124 in Alzheimer's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System [Phase 2]
Phase 2 trial assessing skin tolerability and irritation with 3- and 7-day applications of the DTP-System in elderly Alzheimer's patients ha…
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Bryostatin 1 in Alzheimer's disease was terminated, with results posted in 2016 assessing safety, efficacy, pha…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Effect of AQW051 in Patients With Memory Impairment [Phase 2]
Phase 2 trial of AQW051 in memory impairment (Mild Alzheimer's disease and amnestic mild cognitive impairment) has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial by VTBIO Co. LTD investigated optimal dosage and administration for Alzheimer's disease; the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease
This report outlines the results of a retrospective cohort study evaluating the efficacy of Axona, a medium-chain triglyceride product, in p…
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
A long-term extension Phase 2 study of the Alzheimer's vaccine ACC-001 with QS-21 in mild to moderate Alzheimer's disease was terminated, an…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Effect of NeuroAD on the Cognitive Function of Alzheimer Patients [NA]
Clinical trial update indicating the completion of a study evaluating NeuroAD for cognitive function in Alzheimer's disease patients.
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of the PET imaging agent [18F]NAV4694 in subjects with probable Alzheimer's d…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions [Phase 2]
Phase 2 trial assessing the effect of EGb761 (Ginkgo biloba extract) on brain glucose metabolism in elderly participants categorized by cogn…
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Semantic Memory, Financial Capacity, and Brain Perfusion in Mild Cognitive Impairment (MCI) (CASL)
The update summarizes results from a completed clinical trial evaluating semantic memory, financial capacity, and brain perfusion in individ…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Effects of Light-therapy in Alzheimer's Disease [NA]
Clinical trial updating the effects of light-therapy for Alzheimer's disease has completed, indicating the study has reached its completed s…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil [Phase 2]
A Phase 2 trial evaluated different doses of SAR110894 on cognition in patients with mild to moderate Alzheimer's disease who are on donepez…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Alzheimer's Disease Multiple Intervention Trial [NA]
This update indicates that the Alzheimer's disease multiple intervention trial at Indiana University has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial evaluating a vitamin/nutriceutical formulation for Alzheimer's disease and mild cognitive impairment has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: New Approach for Treatment of Behavioral Disorders in Alzheimer's Disease (Alzheimer's Behavioral and Cognitive Disorders) [NA]
Clinical trial update for a new approach to treating behavioral disorders in Alzheimer's disease; study completed with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease [Phase 2]
A Phase 2 study evaluating amyloid imaging and safety of ACC-001 in subjects with early Alzheimer's disease was completed, with results post…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease [Phase 1, Phase 2]
Clinical trial update on the safety and potential efficacy of umbilical cord-derived mesenchymal stem cells for Alzheimer's disease in Phase…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: 24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion [Phase 2]
Pharnext reports the completion of a 24-week open-label extension study evaluating PXT00864 in mild Alzheimer's disease after completion of …
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Dose Response Study of Aerobic Exercise in Older Adults [EARLY_Phase 1]
Results from an early-phase dose-response study of aerobic exercise in older adults with Alzheimer's disease have been posted following tria…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD) [Phase 2]
A Phase 2 pilot study evaluating PXT00864 in patients with mild Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Bexarotene Amyloid Treatment for Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating bexarotene as an amyloid-targeting treatment for Alzheimer's disease has completed, with results posted in…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: FluoroAv45 Imaging Research-in Alzheimer's Disease [Phase 2]
Phase 2 imaging trial using FluoroAv45 in Alzheimer's disease and mild cognitive impairment has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of multiple ascending doses of GC021109 in adults with mild to moderate …
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: " The Eyes Have it " : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease
This clinical trial update reports on ocular saccade abnormalities observed in prodromal Alzheimer's disease and notes that the study has co…